New review highlights need for proactive care in SM-related bone disease
In systemic mastocytosis, mast cells release substances that disturb the normal balance of bone health and can lead to osteoporosis.
In systemic mastocytosis, mast cells release substances that disturb the normal balance of bone health and can lead to osteoporosis.
Measuring levels of a chemical in the blood called diamine oxidase during anaphylaxis could help doctors diagnose patients with hidden SM.
A new clinical trial published on ClinicalTrials.gov is underway to better understand how indolent SM affects people and how it is managed.
Systemic mastocytosis (SM) is associated with more severe symptom flares than cutaneous mastocytosis (CM), according to a recent study.
A recent study identified previously unknown side effects from epinephrine, a treatment carried by many with SM.
Indolent SM may cause the body to age faster than normal, according to a recent study published in the journal Innovation in Aging.
There is a strong link between mastocytosis and serious allergic reactions to insect stings, especially from insects like bees and wasps.
When children develop small, uniform reddish-brown spots or bumps on their back, belly, or limbs, it may be a sign of SM.
In people with SM, mast cells may contribute to anemia by breaking down red blood cells.
Results from a phase 2 clinical trial suggest bezuclastinib may help treat the underlying cause of nonadvanced SM, as well as its symptoms.